| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/09/2000 | EP0977991A1 Monoclonal antibodies to human cd6 |
| 02/09/2000 | EP0977893A1 Reagents and methods useful for detecting diseases of the prostate |
| 02/09/2000 | EP0977887A2 Member of the tnf family useful for treatment and diagnosis of disease |
| 02/09/2000 | EP0977881A1 Expression of a modified foamy virus envelope protein |
| 02/09/2000 | EP0977880A2 Materials and methods for treatment of retinal diseases |
| 02/09/2000 | EP0977879A2 Eukaryotic gene expression cassette and uses thereof |
| 02/09/2000 | EP0977873A1 Method for cleavage of fusion proteins |
| 02/09/2000 | EP0977872A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/09/2000 | EP0977871A1 Neurotrypsin |
| 02/09/2000 | EP0977862A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/09/2000 | EP0977860A1 Ngf variants |
| 02/09/2000 | EP0977859A1 The neurotrophic factor nnt-1 |
| 02/09/2000 | EP0977858A1 Chicken neuropeptide gene useful for poultry production |
| 02/09/2000 | EP0977857A1 Human c-maf compositions and methods of use thereof |
| 02/09/2000 | EP0977856A1 Lag-3 splice variants |
| 02/09/2000 | EP0977855A2 Polypeptides associated with activator receptors and their biological applications |
| 02/09/2000 | EP0977854A2 Truncated vegf-related proteins |
| 02/09/2000 | EP0977853A1 Secreted proteins and polynucleotides encoding them |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977851A2 Secreted proteins and polynucleotides encoding them |
| 02/09/2000 | EP0977850A1 Edg-1-like receptor |
| 02/09/2000 | EP0977849A1 Leukemia associated genes |
| 02/09/2000 | EP0977848A1 Human theta subunit of the gaba-a receptor |
| 02/09/2000 | EP0977847A1 Brca2 transcriptional activator domain and uses thereof |
| 02/09/2000 | EP0977845A1 Human sodium-dependent phosphate cotransporter |
| 02/09/2000 | EP0977844A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof |
| 02/09/2000 | EP0977843A1 Novel human transmembrane 4 superfamily protein |
| 02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 02/09/2000 | EP0977841A2 Materials and methods for ribozyme treatment of retinal diseases |
| 02/09/2000 | EP0977839A1 Circular dna vectors for synthesis of rna and dna |
| 02/09/2000 | EP0977835A1 Use of a zwitterionic detergent/surfactant for purifying glutamic acid decarboxylase (gad) and a composition containing gad |
| 02/09/2000 | EP0977834A2 Human serine protease precursor |
| 02/09/2000 | EP0977779A1 Mammalian cytokines; related reagents and methods |
| 02/09/2000 | EP0977777A1 A novel th2-specific gene |
| 02/09/2000 | EP0977776A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2 |
| 02/09/2000 | EP0977774A1 Antipathogenic synthetic peptides and compositions comprising them |
| 02/09/2000 | EP0977773A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977772A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977768A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/09/2000 | EP0977595A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | EP0977591A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 02/09/2000 | EP0977590A1 Human monoclonal antibodies |
| 02/09/2000 | EP0977586A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 02/09/2000 | EP0977585A1 Methods for diagnosing and treating body weight related disorders in animals |
| 02/09/2000 | EP0977584A1 PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE |
| 02/09/2000 | EP0977583A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 02/09/2000 | EP0977582A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 02/09/2000 | EP0977581A1 Histone containing composition to treat rheumatoid arthritis |
| 02/09/2000 | EP0977580A1 MATERIALS AND METHODS RELATING TO INHIBITING THE INTERACTION OF p53 AND mdm2 |
| 02/09/2000 | EP0977579A1 Gastrin receptor-avid peptide conjugates |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/09/2000 | EP0977577A1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | EP0651652B1 Treatment for sensitive teeth |
| 02/09/2000 | EP0618808B1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 02/09/2000 | EP0608313B1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 02/09/2000 | EP0531407B1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 02/09/2000 | EP0487610B1 Prohormone cleavage site blocking antibody |
| 02/09/2000 | CN1244215A Improved method for the production and purification of adenoviral vectors |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1244127A Freeze-dried composition of bone morphogenetic protein human MP52 |
| 02/09/2000 | CN1243750A Genetically engineered drug for preventing cancer metastasis and its preparing process |
| 02/09/2000 | CN1243748A Anticancer action of cell factor derivative |
| 02/09/2000 | CN1049223C Improved meninggococcal polysaccharide conjugate vaccine |
| 02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 02/08/2000 | US6022994 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 02/08/2000 | US6022962 Hairpin ribozymes |
| 02/08/2000 | US6022958 cDNAs coding for members of the carcinoembryonic antigen family |
| 02/08/2000 | US6022955 Fatty acid -- pulmonary surfactant conjugates |
| 02/08/2000 | US6022951 Streptavidin mutants |
| 02/08/2000 | US6022949 Protein which regulates fungal susceptibility to fungicide; for screening of fungicides; for producing modulators of fungicide |
| 02/08/2000 | US6022878 Inhibitors of rotamase enzyme activity |
| 02/08/2000 | US6022861 Ketoheterocyclic inhibitors of factor Xa |
| 02/08/2000 | US6022860 Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation |
| 02/08/2000 | US6022859 Inhibitors of β-amyloid toxicity |
| 02/08/2000 | US6022858 Pharmaceutical formulation of human-growth hormone pretreated with zinc salt |
| 02/08/2000 | US6022856 For treatment of hormonal or neurological disorders in which the natural nt-r2 receptor and/or neurotensin is involved; schizophrenia; analgesics; muscle contractions; gastrointestinal disorders |
| 02/08/2000 | US6022855 Novel variants of the naturally-occurring protease inhibitor, alpha1-antitrypsin and derived peptides comprising a sequence of-arg-xaa-xaa-arg-; viricides; bactericides; blocking of endoproteolytic activation of a bacterial toxin |
| 02/08/2000 | US6022854 Platelet specific therapeutic compound and method of treating |
| 02/08/2000 | US6022853 Morphogen-enriched dietary composition |
| 02/08/2000 | US6022852 Comprising cyclosporin a, tocopherol, polyethylene glycol 1000 succinate and, optionally, an emulsifier, with the exception of vegetable oil or fat; administering by mouth; kidney disorders; topical; psoriasis, wound healing agents |
| 02/08/2000 | US6022851 Cyclic polypeptides for treatment and prophylaxis of antibiotic-resistant bacterial infectious diseases by administration with an excipient |
| 02/08/2000 | US6022850 Use of hemoglobin in the treatment of stroke |
| 02/08/2000 | US6022849 Particularly relates to recombinant hemoglobins that have altered geometry or polarity around the distal portion of the heme pocket; blood transfusions; reduced binding of niric acid and carbon monoxide |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022847 Polypeptides modulate adhesion or modulate or indicate salivary gland |
| 02/08/2000 | US6022745 Homologously recombinant slow growing mycobacteria and uses therefor |
| 02/08/2000 | US6022740 Nucleic acid sequence that codes a oncogene polypeptide; for detection of modulators of dystrophyn mediated signal transduction; for reversing oncogenic transformation of cells; for treatment of signal transduction related disease |
| 02/08/2000 | US6022736 Nucleic acid vectors comprising DNase I hypersensitive sites |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022720 Bax protein channel formation |
| 02/08/2000 | US6022711 Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1 |
| 02/08/2000 | US6022710 Polynucleotide sequence coding a bacterial transcription factor; for the accurate diagnosis, treatment and prevention of bacterial infection; bactericides |
| 02/08/2000 | US6022709 Nucleic acid encoding an altered telomere repeat binding factor |
| 02/08/2000 | US6022707 Ras-like protein |
| 02/08/2000 | US6022706 Div1b |
| 02/08/2000 | US6022697 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |